Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
30
5
6
7
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
1
2
Federles Master Tutorial On Abdominal Imaging
2020-06-29 - 2020-07-01    
All Day
The course is designed to provide the tools for participants to enhance abdominal imaging interpretation skills utilizing the latest imaging technologies. Time: 1:00 pm - [...]
IASTEM - 864th International Conference On Medical, Biological And Pharmaceutical Sciences ICMBPS
2020-07-01 - 2020-07-02    
All Day
IASTEM - 864th International Conference on Medical, Biological and Pharmaceutical Sciences ICMBPS will be held on 3rd - 4th July, 2020 at Hamburg, Germany . [...]
International Conference On Medical & Health Science
2020-07-02 - 2020-07-03    
All Day
ICMHS is being organized by Researchfora. The aim of the conference is to provide the platform for Students, Doctors, Researchers and Academicians to share the [...]
Mental Health, Addiction, And Legal Aspects Of End-Of-Life Care CME Cruise
2020-07-03 - 2020-07-10    
All Day
Mental Health, Addiction Medicine, and Legal Aspects of End-of-Life Care CME Cruise Conference. 7-Night Cruise to Alaska from Seattle, Washington on Celebrity Cruises Celebrity Solstice. [...]
ISER- 843rd International Conference On Science, Health And Medicine ICSHM
2020-07-03 - 2020-07-04    
All Day
ISER- 843rd International Conference on Science, Health and Medicine (ICSHM) is a prestigious event organized with a motivation to provide an excellent international platform for the academicians, [...]
04 Jul
2020-07-04    
12:00 am
ICRAMMHS is to bring together innovative academics and industrial experts in the field of Medical, Medicine and Health Sciences to a common forum. All the [...]
6th Annual Formulation And Drug Delivery Congress
2020-07-08 - 2020-07-09    
All Day
Meet and learn from experts in the pharmaceutical sciences community to address critical strategic developments and technical innovation in formulation, drug delivery and manufacturing of [...]
7th Global Conference On Pharma Industry And Medical Devices
2020-07-08 - 2020-07-09    
All Day
The Global Conference on Pharma Industry and Medical Devices GCPIMD is to bring together innovative academics and industrial experts in the field of Pharmacy and [...]
IASTEM - 868th International Conference On Medical, Biological And Pharmaceutical Sciences ICMBPS
2020-07-09 - 2020-07-10    
All Day
IASTEM - 868th International Conference on Medical, Biological and Pharmaceutical Sciences ICMBPS will be held on 9th - 10th July, 2020 at Amsterdam, Netherlands . [...]
2nd Annual Congress On Antibiotics, Bacterial Infections & Antimicrobial Resistance
2020-07-09 - 2020-07-10    
All Day
EURO ANTIBIOTICS 2020 invites all the participants from all over the world to attend 2nd Annual Congress Antibiotics, Bacterial infections & Antimicrobial Resistance to be [...]
Events on 2020-06-29
Events on 2020-07-02
Latest News

The effect of the COVID-19 epidemic on health and care – is this a portent of the ‘new normal’?

The effect of the COVID-19 epidemic on health and care – is this a portent of the 'new normal'?

The approach which differing countries have adopted has been fascinating to watch with the far east particularly South Korea and Singapore adopting very technologically advanced digital solutions towards contact tracing and also using testing very extensively. Differences in Europe have also emerged in terms of approach between countries with Germany having the highest rate of testing and the greatest number of ventilated beds (and as critically, the trained experienced workforce to support and deploy them) potentially having lower death rates as a result covid-19 epidemic on health

It is also becoming clearer that the effect on COVID-19 upon health and care systems goes beyond the disease it produces as health systems have to somehow contemporaneously cope with the existing levels of non-communicable diseases. This is an enormous challenge since in all too many cases, the systems cannot cope with the volume of patients needing care as a result of COVID-19, even if there were no other calls associated with cardiovascular, pulmonary and metabolic diseases and cancer.

The effect of this has varied from country to country but some patterns are emerging. For example, primary care has long held the promise that problems like access and care could be delivered digitally, but to date the scale of actual digital adoption has been disappointing, and the aspirations we have all had around digital transformation have had to be tempered by the reality of slower speeds of adoption than anticipated. This well could be changing and the 2020s could be remembered not only as the age of COVID-19 but also as the age when digital transformation started to come of age and become the mainstream solution.

History also teaches us that it is difficult to put the “genie back in the bottle” once it is released and the challenges of a diminishing and ageing workforce and consumer pressure makes it very unlikely that the post COVID-19 era will be similar to the pre COVID-19 era.

The effect of COVID-19 upon digital solutions around delivery of healthcare has been and continues to be very significant and it is accelerating as fast as COVID-19 is moving across the globe. Thus, considering this new post COVID-19 world, they can be thought of as:

  • Directly associated with the epidemic  

There are many lessons to be learnt from the use of technology in public health surveillance, from the linking of data in sentinel labs to the development of technological solutions to immediately link testing in various geographical locations, thus enabling insights to be drawn around spread

When it comes to the use of technology around contact tracing, some countries like South Korea have developed the use of smartphone technology to assist in better managing contacts with quite exceptional results.

From the perspective of health provision, issues like central dashboards to better manage bed and care availability within hospital settings have been shown to significantly improve efficient bed utilisation, as demonstrated by some systems in Germany.

The use of telemedicine for direct patient care for public health emergencies has been well described. A central strategy for health care surge control for patients suspected with COVID-19 is forward triage for patients before they attend emergency departments. The utilisation of a digital first approach around access could deliver this with a personalisation and consistency we could not otherwise deliver.  There are plenty of examples in the US that use personalised online screening that are already delivering this.

The potential for telemedicine is only limited by our imagination. From delivering better solutions in terms of disaster planning, like a scenario where a whole health workforce is quarantined after infection or exposure and then able to be deployed digitally from home, to the better care of affected patients by dynamically being able to communicate with them remotely at scale and in real-time, irrespective of their geographic location.

  • As a result of the epidemic

The post-COVID world is likely to be remembered as the time when the care of other medical interactions like the provision of primary care or the management of non-communicable diseases shifted to digital modalities as the default rather than the exception. This new post COVID-19 age is also likely to then enable all the other technologies we have been celebrating, like insights associated with AI, and the potential that 5G gives us in terms of the Internet of things to all converge in a whole variety of ways. We are seeing this happen in real-time and at a pace we could never have imagined. In England, primary care at scale has now finally started to embrace telehealth and has deployed a new digital first pathway as a route to managing streaming of care to the appropriate place. This would have been beyond the limits of the possible only a few weeks ago.

There is much we need to do. We need to incorporate appropriate and robust governance in the deployment of these new modalities and also include robust clinical decision support within our deployments as a rule rather than as an exception.

Our scope and scale of our challenges is changing. We have been encouraging the adoption of digital transformation and this needs to continue. We also now need to assist our members in managing the complexities of governance and clinical decision support.

The other significant change we can already see accelerating is the adoption of precision health both in more personalised and predictive public health, but also in utilising digital technology in empowering people to better self-manage in non-communicable disease.

Furthermore, we need to understand that this new health and care world will look very different to the world we have been used to, but the likelihood is that by adoption of these new digital modalities in the care of people we can get closer to delivering what is our mission at HIMSS, the delivery of better care to everyone, everywhere.